Cargando…

Irbesartan in experimental diabetic nephropathy

Detalles Bibliográficos
Autores principales:	Mahajan, Rajiv, Gupta, Kapil, Singh, Navyug Raj
Formato:	Texto
Lenguaje:	English
Publicado:	Medknow Publications 2010
Materias:	Letters to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2937327/ https://www.ncbi.nlm.nih.gov/pubmed/20871777 http://dx.doi.org/10.4103/0253-7613.66849

Ejemplares similares

Biochemical effects of irbesartan in experimental diabetic nephropathy
por: Vaishya, Richa, et al.
Publicado: (2009)

Intradetrusor botulinum toxin type A in refractory overactive bladder: A potential future treatment
por: Mahajan, Rajiv, et al.
Publicado: (2011)

Clinical efficacy of linagliptin combined with irbesartan in patients with diabetic nephropathy
por: Liu, Jie, et al.
Publicado: (2022)

A Case of Sprue-like Enteropathy Associated With Valsartan and Irbesartan
por: Yoo, Seo Yeon, et al.
Publicado: (2022)

Cytochrome modulation decreases the risk of cataract: Is the basic hypothesis flawless?
por: Mahajan, Rajiv, et al.
Publicado: (2009)

Conversion from migraine without aura to typical aura without headache after irbesartan
por: Pinessi, L., et al.
Publicado: (2005)

Basic Medical Scientists Association: A forum for research integration
por: Jain, Sheela, et al.
Publicado: (2011)

ACE polymorphism and diabetic nephropathy
por: Wiwanitkit, V.
Publicado: (2010)

Current scenario of attitude and knowledge of physicians about rational prescription: A novel cross-sectional study
por: Mahajan, Rajiv, et al.
Publicado: (2010)

Changes of Necroptosis in Irbesartan Medicated Cardioprotection in Diabetic Rats
por: Xu, Qingmei, et al.
Publicado: (2021)

Irbesartan Ameliorates Diabetic Nephropathy by Suppressing the RANKL-RANK-NF-κB Pathway in Type 2 Diabetic db/db Mice
por: Chen, Xiao-Wen, et al.
Publicado: (2016)

Prevalence of diabetic nephropathy in an underserved rural community
por: Jindal, R. M., et al.
Publicado: (2012)

Angiopoietin-1: an early biomarker of diabetic nephropathy?
por: Butler, Alexandra E., et al.
Publicado: (2021)

Corrigendum to “Irbesartan Ameliorates Diabetic Nephropathy by Suppressing the RANKL-RANK-NF-κB Pathway in Type 2 Diabetic db/db Mice”
por: Chen, Xiao-Wen, et al.
Publicado: (2016)

P-drug concept and the undergraduate teaching
por: Singh, Navyug Raj
Publicado: (2008)

Prevention and management of type 2 diabetes: Potential role of genomics
por: Mahajan, Rajiv, et al.
Publicado: (2014)

The renoprotective effects of pentoxifylline: beyond its role in diabetic nephropathy
por: Kapoor, Shailendra
Publicado: (2013)

Membranous Nephropathy with Collapse: Poor Prognosis
por: Bharati, Joyita, et al.
Publicado: (2020)

Response to “Health economics in India: The case of diabetes mellitus”
por: Gupta, Yashdeep, et al.
Publicado: (2014)

Absence of diabetic retinopathy in a patient who has had diabetes mellitus for 69 years, and inadequate glycemic control: case presentation: response
por: Raman, Rajiv, et al.
Publicado: (2010)

Angiotensin converting enzyme gene polymorphism in type 2 diabetics with nephropathy
por: Naresh, V. V. S., et al.
Publicado: (2010)

Effect of vitamin D on insulin resistance and nephropathy in type 2 diabetes
por: Nasri, Hamid, et al.
Publicado: (2014)

Effects of irbesartan on serum uric acid levels in patients with hypertension and diabetes
por: Nakamura, Makiko, et al.
Publicado: (2014)

Oxalate Nephropathy
por: Etta, Praveen K., et al.
Publicado: (2023)

Development of binary dispersions and nanocomposites of irbesartan with enhanced antihypertensive activity
por: Puri, Vivek, et al.
Publicado: (2020)

Antiglomerular Basement Membrane Disease Combined with IgA Nephropathy
por: Gupta, Yashita, et al.
Publicado: (2019)

Mechanism of tangshen formula in treating diabetic nephropathy revealed by network pharmacology approach
por: Quan, Na, et al.
Publicado: (2021)

Letter Regarding Normal Albuminuria in Patients With Autopsy-Proven Advanced Diabetic Nephropathy
por: Heyman, Samuel N., et al.
Publicado: (2022)

Long-Term Effects of Irbesartan Treatment and Smoking on Nucleic Acid Oxidation in Patients With Type 2 Diabetes and Microalbuminuria: An Irbesartan in Patients With Type 2 Diabetes and Microalbuminuria (IRMA 2) substudy
por: Broedbaek, Kasper, et al.
Publicado: (2011)

Membranous nephropathy and carbamazepine
por: Sangeetha, B., et al.
Publicado: (2014)

ENDEMIC (BALKAN) NEPHROPATHY
por: Macanović, Momir, et al.
Publicado: (1976)

Endothelial effects of antihypertensive treatment: focus on irbesartan
por: Negro, Roberto
Publicado: (2008)

Fixed combination of irbesartan and hydrochlorothiazide in the management of hypertension
por: Bramlage, Peter
Publicado: (2009)

Response to “Letter Regarding Normal Albuminuria in Patients With Autopsy-Proven Advanced Diabetic Nephropathy”
por: Sasaki, Takaya, et al.
Publicado: (2022)

Rituximab in Primary Membranous Nephropathy With Severe CKD
por: Naik, Sachin, et al.
Publicado: (2023)

Hydroxychloroquine Reduces Proteinuria in Indian Patients With IgA Nephropathy
por: Bagchi, Soumita, et al.
Publicado: (2022)

VIRUSES IN ENDEMIC (BALKAN) NEPHROPATHY
por: Georgescu, Leonida, et al.
Publicado: (1976)

Folding back of central venous catheter in the internal jugular vein: Methods to diagnose it at the time of insertion?
por: Kumar, Amitabh, et al.
Publicado: (2013)

Utility of Determining Autoantibodies to M-type Phospholipase A2 Receptor in Diagnosing Primary Membranous Nephropathy: An Ideal Setting
por: Ramachandran, R., et al.
Publicado: (2017)

Prevalence of and Factors Associated with Nephropathy in Diabetic Patients Attending an Outpatient Clinic in Harare, Zimbabwe: Methodological Issues
por: Pakzad, Reza, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_v02jeoe2938spdf9bq0rj17713